The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...

TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in ...

Sanofi's decision to end development of the drug in myasthenia gravis may lie in the changing landscape of therapies for the disease, including the approval of Argenx' neonatal FC receptor (FcRn ...

The first drug based on 'Trap' technology, which fuses two receptor components and a portion of an antibody molecule called the 'Fc' region, has been given marketing authorization by the US Food ...

Thane Wettig; Interim Chief Executive Officer, Chief Commercial Officer; FibroGen Inc. David Delucia; Vice Presi ...

It’s designated by the DEA as a “drug and chemical of concern,” but it is not considered a controlled substance.

Whether with shots, gum or espressos, players are getting their caffeine fix more than ever to boost performance ...

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...

My 66-year-old husband recently received a diagnosis of heart failure with preserved ejection fraction. He is 5 feet, 7 ...

The FC 25 FUT Fantasy FC tracker has received its first set of upgrades, with Eden Hazard and Joao Felix among its early winners. This EA FC 25 Ultimate Team promo awards boosts for real-world ...